In a seminal proteomic study of unmanipulated CD34+ cells from CML patients and normal individuals by mass spectrometry, p53 and c-MYC were found to be at the center of a CML network involved in the regulation of LSCs57. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.